Medicine and Dentistry
Patient
100%
Chronic Kidney Disease
27%
Therapeutic Procedure
27%
Blood Pressure
27%
Omega-3 Fatty Acid
25%
Hemodialysis
20%
Inpatient
20%
Plasma
18%
Hyponatremia
15%
Mortality
14%
Follow up
13%
Heart Rate Variability
13%
Association
13%
Age
13%
Child
13%
Cardiovascular System
11%
Kidney Graft
10%
Eculizumab
10%
Heart Rate
9%
Acid
9%
Rheumatoid Arthritis
9%
Vascular Resistance
9%
Marker
9%
Hazard Ratio
8%
Diseases
8%
Systemic Lupus Erythematosus
8%
Kidney Function
8%
Incidence
8%
Cardiac Dysrhythmia
8%
Cardiovascular Disease
8%
Transplantation
8%
Combination Therapy
7%
Amaurosis
7%
Atypical Hemolytic Uremic Syndrome
7%
Irbesartan
7%
Protein
7%
Immunoglobulin A Nephropathy
7%
Cohort Analysis
7%
Biological Marker
6%
Infection
6%
Measurement
6%
Supplementation
6%
Hypertension
6%
Analysis
6%
Sudden Cardiac Death
6%
Cannulation
6%
Angiotensin Receptor Antagonist
6%
Placebo
6%
Psoriatic Arthritis
6%
Development
6%
Creatinine
5%
Arterial Stiffness
5%
ANCA Associated Vasculitis
5%
Bone
5%
Systolic Blood Pressure
5%
Fatty Acid
5%
Urine
5%
Male
5%
Kidney
5%
Urinary System
5%
Kidney Denervation
5%
Prevalence
5%
Man
5%
Biochemistry, Genetics and Molecular Biology
Polyunsaturated Fatty Acid
20%
Association
20%
Blood Pressure
19%
Dialysis
14%
Heart Rate Variability
14%
Hemodialysis
13%
Fish
12%
Hyponatremia
12%
Fatty Acid Level
12%
Mortality
11%
Blood Level
11%
Age
9%
Bone Density
9%
Osteoprotegerin
8%
Positron Emission Tomography-Computed Tomography
6%
Vitamin K
6%
Sudden Cardiac Death
6%
Protein
6%
Heart Rate
5%
Survival
5%
Vascular Resistance
5%
Creatinine
5%
Glomerulus Filtration
5%
Time
5%
Nursing and Health Professions
Patient
59%
Chronic Kidney Failure
20%
Inpatient
16%
Confidence Interval
14%
Blood Pressure
14%
Procedures
12%
Mortality
11%
Dialysis
9%
Vascular Resistance
9%
Hyponatremia
8%
Systemic Lupus Erythematosus
8%
Hemodialysis
7%
Incidence
7%
Infection
6%
Irbesartan
6%
Follow up
5%
Angiotensin Receptor Antagonist
5%
Combination Therapy
5%
Kidney Denervation
5%
Prevalence
5%